CLL Emotional Impact Report Press Kit

On June 24, 2022, AbbVie shared findings from the newly launched Emotional Impact Report, a survey of more than 300 chronic lymphocytic leukemia (CLL) patients, caregivers and healthcare providers (HCPs) in the U.S., which uncovered insights about the emotional journey associated with a CLL diagnosis.

Press Kit Items

New Survey Offers Perspective on Mental and Emotional Journey for Patients Diagnosed with Slow-Growing Blood Cancer

- New insights uncover how patients and caregivers cope emotionally during phases of Chronic Lymphocytic Leukemia (CLL)
- The findings also show majority of HCPs view treating CLL patients as different from treating other cancers
- The emotional complexities of this slow-growing cancer point to patient and caregiver need for greater support from HCPs at time of diagnosis

Emotional Impact Report Fact Sheet

The Emotional Impact Report Fact Sheet provides a high-level overview of the survey findings and methodology.

The Emotional Impact Report by the Numbers

The Emotional Impact Report Infographic shares key insights from CLL patients, caregivers and HCPs.

Then and now: A renaissance in blood cancer treatment

See how scientists have nearly doubled some survival rates in a generation, with even more scientific discoveries on the horizon.

Possibilities in CLL care: From lucky cancer to resistant clones

The evolution of care for CLL patients spotlights significant achievements and advancements.

Riding the roller coaster: The emotional impact of living with CLL

Life with chronic lymphocytic leukemia is full of unknowns. How can patients find ways to take control?